Page last updated: 2024-12-09

1,3-dibutyl-2-thiourea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-dibutyl-2-thiourea, also known as DBTU, is an organic compound that belongs to the thiourea family. It is a white, crystalline solid with a faint, sulfurous odor.

**Structure and Properties:**

* **Formula:** C9H20N2S
* **Molecular Weight:** 192.35 g/mol
* **Melting Point:** 66-68 °C
* **Boiling Point:** 240-245 °C

**Importance in Research:**

1,3-dibutyl-2-thiourea (DBTU) plays a significant role in various research areas, including:

**1. Organic Synthesis:**

* **Catalyst:** DBTU acts as a highly effective catalyst in a wide range of organic reactions, including:
* **Ring-opening metathesis polymerization (ROMP):** DBTU is used as a catalyst for the polymerization of cyclic olefins to form polymers with controlled molecular weights and structures.
* **Cyclopropanation:** DBTU catalyzes the formation of cyclopropanes from alkenes and diazoalkanes.
* **Carbon-carbon bond formation:** DBTU promotes various carbon-carbon bond-forming reactions, such as Michael additions and aldol condensations.
* **Reagent:** DBTU can also be used as a reagent for the synthesis of various organic compounds, including thioureas, isothiocyanates, and amides.

**2. Materials Science:**

* **Polymer Synthesis:** DBTU is employed in the synthesis of novel polymers with unique properties, such as high thermal stability and conductivity.
* **Nanomaterials:** DBTU can be used in the synthesis of nanoparticles, nanowires, and other nanomaterials with potential applications in electronics, catalysis, and biomedical engineering.

**3. Analytical Chemistry:**

* **Spectroscopy:** DBTU exhibits characteristic spectroscopic properties that can be utilized for analytical purposes, such as UV-Vis spectroscopy and mass spectrometry.
* **Chromatography:** DBTU can serve as a stationary phase in chromatography, allowing for the separation and identification of different compounds.

**4. Environmental Applications:**

* **Pollution Remediation:** DBTU has shown potential for the removal of heavy metals and other pollutants from wastewater and soil.

**5. Medicinal Chemistry:**

* **Drug Discovery:** DBTU is being explored as a potential lead compound for the development of new drugs, especially those targeting the nervous system and cancer.

**In summary, 1,3-dibutyl-2-thiourea (DBTU) is a versatile compound with a wide range of applications in research. Its catalytic activity, synthetic versatility, and potential for use in various scientific fields make it an important tool for chemists, materials scientists, and other researchers.**

1,3-dibutyl-2-thiourea: may cause contact dermatitis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N,N'-dibutylthiourea : Thiourea in which each nitrogen carries a butyl substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2723622
CHEMBL ID3183795
CHEBI ID138415
SCHEMBL ID17219
SCHEMBL ID11844895
MeSH IDM0106444

Synonyms (66)

Synonym
pennzone b
dibutylthiourea
nsc-3735
n,n'-dibutylthiourea
nsc4148
1,3-di-n-butyl-2-thiourea
urea,3-di-n-butyl-2-thio-
usaf ek-2138
1,3-dibutyl-2-thiourea
nsc-4148
wln: suym4 & m4
109-46-6
thiourea,n'-dibutyl-
1,3-dibutylthiourea
nsc3735
urea,3-dibutyl-2-thio-
urea, 1,3-dibutyl-2-thio-
thiourea, n,n'-dibutyl-
n,n'-di-n-butylthiourea
n,n'-dibutylthiourea, 97%
urea, 1,3-di-n-butyl-2-thio-
urea,1,3-dibutyl-2-thio-
brn 0507434
einecs 203-674-6
thiate u
nsc 3735
ai3-08621
MAYBRIDGE1_007237
inchi=1/c9h20n2s/c1-3-5-7-10-9(12)11-8-6-4-2/h3-8h2,1-2h3,(h2,10,11,12
STK378358
dbtu
sym-dibutylthiourea
s-dibutylthiourea
CHEBI:138415
D0301
AKOS003718653
HMS562A21
A802042
NCGC00248245-01
BBL002999
1,3-dibutyl-thiourea
unii-3154m2q6gd
3154m2q6gd ,
tox21_300986
dtxcid6022187
cas-109-46-6
NCGC00254888-01
dtxsid8042187 ,
bis(butylamino)methane-1-thione
FT-0629391
di-n-butyl-2-thiourea, 1,3-
AB01334003-02
SCHEMBL17219
1,3-di-n-butylthiourea
1.3-dibutyl-thiourea
SCHEMBL11844895
CHEMBL3183795
n,n'-di-normal-butylthiourea
mfcd00004926
J-002288
F0001-0195
AS-19751
Q19059365
A934580
NCGC00248245-02
CS-0076311

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Daily dosage levels (mg/kg/day) were ETU at 0, 15, 25 and 35; DMT at 0, 15, 25, 50, 100, and 200; DBT at 0, 15, 25, 50, 100, and 200; and DPT at 0, 25, 50, 100, and 200."( Difference in the developmental toxicity of ethylenethiourea and three N,N'-substituted thiourea derivatives in rats.
de Ceaurriz, J; Langonne, I; Sabate, JP; Saillenfait, AM, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
thioureasCompounds of general formula RR'NC(=S)NR''R'''.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency68.58960.000714.592883.7951AID1259368
AR proteinHomo sapiens (human)Potency51.95360.000221.22318,912.5098AID743035; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency48.55770.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency45.91740.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency8.63490.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency24.49790.003041.611522,387.1992AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency42.42060.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency63.70310.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency54.94100.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency34.37620.005428.02631,258.9301AID1346982
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency54.94100.001024.504861.6448AID743215
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency46.22710.023723.228263.5986AID743241
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency51.95360.057821.109761.2679AID1159526; AID1159528
Caspase-7Cricetulus griseus (Chinese hamster)Potency61.13060.006723.496068.5896AID1346980
caspase-3Cricetulus griseus (Chinese hamster)Potency61.13060.006723.496068.5896AID1346980
heat shock protein beta-1Homo sapiens (human)Potency29.14140.042027.378961.6448AID743210; AID743228
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (36.36)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.76 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies8 (61.54%)4.05%
Observational0 (0.00%)0.25%
Other5 (38.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]